United States Food & Drug Administration (FDA) Grants
FDA GRANTS MESOBLAST RARE PEDIATRIC DISEASE DESIGNATION FOR REVASCOR® (REXLEMESTROCEL-L) IN CHILDREN WITH CONGENITAL HEART DISEASE...
Stay updated with breaking news from Results Published. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FDA GRANTS MESOBLAST RARE PEDIATRIC DISEASE DESIGNATION FOR REVASCOR® (REXLEMESTROCEL-L) IN CHILDREN WITH CONGENITAL HEART DISEASE...
Pressure BioSciences’ UltraShear Platform Maintains Nutritional, Sensory, ...
Results Published in European Journal of Human Genetics Demonstrate Unprecedented Insights to Accelerate Potential Treatment OptionsInclusion of 602 patients from 47 countries represents the world’s...
1,963 recommended for government jobs in 40th BCS results
STIMO-BRIDGE Study Results Published in Nature Medicine THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014). ONWARD